MedPath

JAIMIESS

These highlights do not include all the information needed to use JAIMIESS safely and effectively. See full prescribing information for JAIMIESS. Initial U.S. Approval: 1982

Approved
Approval ID

7fe3a0d4-533f-0bdf-e60a-20c69bdf79fc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 21, 2023

Manufacturers
FDA

Xiromed, LLC.

DUNS: 080228637

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

levonorgestrel / ethinyl estradiol and ethinyl estradiol

PRODUCT DETAILS

NDC Product Code70700-123
Application NumberANDA203770
Marketing CategoryC73584
Route of AdministrationN/A
Effective DateJanuary 1, 2018
Generic Namelevonorgestrel / ethinyl estradiol and ethinyl estradiol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

JAIMIESS - FDA Drug Approval Details